Loading chat...

NJ A1636

Bill

Status

Introduced

1/13/2026

Primary Sponsor

Sean Kean

Click for details

Origin

General Assembly

2026-2027 Regular Session

AI Summary

  • Classifies 7-Hydroxymitragynine (7-OH), a psychoactive alkaloid found in kratom, as a Schedule I controlled dangerous substance in New Jersey, defining it as having high abuse potential and no accepted medical use

  • Prohibits the sale, distribution, and manufacture of any product containing 7-OH, with manufacturers and distributors required to issue immediate recalls for affected products

  • Requires retailers to remove recalled products within 48 hours of notice and return inventory to manufacturers/distributors within 30 business days at the manufacturer's expense

  • Establishes escalating criminal penalties for violations: fourth-degree crime for first offense (up to 18 months imprisonment, $10,000 fine), third-degree for second offense, and second-degree for third or subsequent offenses (5-10 years, up to $150,000 fine)

  • Follows FDA recommendations from July 29, 2025 to schedule 7-OH, citing concerns that concentrated products sold in gas stations, vape shops, and online can contain up to 500% more 7-OH than naturally occurs in kratom and may be as addictive as opioids

Legislative Description

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

Consumer Affairs

Last Action

Introduced, Referred to Assembly Consumer Affairs Committee

1/13/2026

Committee Referrals

Consumer Affairs1/13/2026

Full Bill Text

No bill text available